Johnson & Johnson JNJ:NYSE

Last Price$130.31NYSE Previous Close - Last Trade as of 4:00PM ET 7/19/19

Today's Change-1.76(1.33%)
Bid (Size)$130.00 (2)
Ask (Size)$130.28 (8)
Day Low / High$130.19 - 132.39
Volume8.3 M

View Pharmaceuticals: Major IndustryPeer Comparison as of 07/19/2019


Johnson & Johnson ( NYSE )

Price: $130.31
Change: -1.76 (1.33%)
Volume: 8.3 M
4:00PM ET 7/19/2019

Pfizer Inc ( NYSE )

Price: $42.77
Change: -0.29 (0.67%)
Volume: 22.3 M
4:02PM ET 7/19/2019

Merck & Co Inc ( NYSE )

Price: $81.39
Change: -1.30 (1.57%)
Volume: 11.5 M
4:00PM ET 7/19/2019

Eli Lilly and Co ( NYSE )

Price: $106.75
Change: -0.05 (0.04%)
Volume: 4.8 M
4:00PM ET 7/19/2019

AbbVie Inc ( NYSE )

Price: $68.54
Change: +0.29 (0.42%)
Volume: 9.8 M
4:00PM ET 7/19/2019

Read more news Recent News

Sector Update: Most Health Care Majors Trade Higher Pre-Bell Friday
9:20AM ET 7/19/2019 MT Newswires

Top Health Care Stocks: JNJ: -0.05% PFE: +0.21% ABT: +0.27% MRK: +0.36% AMGN: +0.45% Health care majors were mostly higher in Friday's pre-bell trade. ...

Halozyme Says J&J Unit Using Its Technology Makes Application for Cancer Drug
8:57AM ET 7/19/2019 MT Newswires

Halozyme Therapeutics (HALO) said pre-market Friday that Janssen-Cilag International NV, a unit of Johnson & Johnson (JNJ), has submitted an extension...

Sector Update: Health Care Majors Flat To Higher Pre-Bell Thursday
9:15AM ET 7/18/2019 MT Newswires

Top Health Care Stocks: JNJ: +0.01% PFE: Flat ABT: +0.62% MRK: Flat AMGN: Flat Health care majors were flat to higher pre-bell Thursday. Early movers...

Analysts Increase Johnson & Johnson's 2019 Estimate but Lower Q3, and 2020 Targets
1:51AM ET 7/18/2019 MT Newswires

Earnings targets for Johnson & Johnson Co's (NYSE:JNJ, Recent Price: 131.86) Q3 ending September 30, 2019, and the full year forecasts for 2019 and 2020...

View all Commentary and Analysis

Buy Johnson & Johnson, Dividend King With Steady Growing Defensive Earnings
4:42PM ET 7/19/2019 Seeking Alpha

The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian Pacific
10:06AM ET 7/19/2019 Zacks

The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas and Canadian...

Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, Pipeline/Regulatory Updates in Focus
8:53AM ET 7/19/2019 Zacks

J&J (JNJ) and Novartis (NVS) set the earnings season in motion for the pharma space. FDA...

Dow 30 Stock Roundup: MSFT, JPM, IBM, JNJ, GS Earnings Impress
7:56AM ET 7/19/2019 Zacks

The Dow endured a volatile week, primarily due to renewed trade tensions, after gaining strongly...

Company Profile

Business DescriptionJohnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. View company web site for more details
AddressOne Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
Number of Employees135,100
Recent SEC Filing07/16/20198-K
Chairman & Chief Executive OfficerAlex Gorsky
Chief Financial Officer & Executive Vice PresidentJoseph J. Wolk
Chief Scientific OfficerPaulus Stoffels
Executive Vice President & General CounselMichael H. Ullmann

Company Highlights

Price Open$132.25
Previous Close$132.07
52 Week Range$121.00 - 148.99
Market Capitalization$346.0 B
Shares Outstanding2.7 B
SectorHealth Technology
IndustryPharmaceuticals: Major
Current Dividend / Yield$0.95 / 2.88%
Dividend Ex-Date08/26/2019
Dividend Pay-Date09/10/2019
Dividend Yield 5 Year AverageN/A
Next Earnings Announcement10/15/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings24.46
Earnings per Share$6.73
Beta vs. S&P 500N/A
Revenue$81.5 B
Net Profit Margin17.99%
Return on Equity23.85%

Analyst Ratings as of 07/12/2019

Consensus RecommendationConsensus Icon
Powered by Factset